First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]
Foster K +10 more
europepmc +1 more source
Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA. [PDF]
Shah HA +9 more
europepmc +1 more source
Epidemiology of invasive meningococcal disease, Japan, 2013 to 2023. [PDF]
Kobayashi M +6 more
europepmc +1 more source
Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare <i>porA</i> genosubtype (19-54, 15), Spain, March to April 2024. [PDF]
Abad R +12 more
europepmc +1 more source
Invasive Meningococcal Disease in Children: Outcomes and Risk Factors for Sequelae and Fatal Cases in Greece. [PDF]
Poulikakos P +15 more
europepmc +1 more source
Global epidemiology of serogroup Y invasive meningococcal disease: a literature review. [PDF]
Tin Tin Htar M +3 more
europepmc +1 more source
Twenty-Eight Years of Invasive Meningococcal Disease Surveillance in the Autonomous Province of Vojvodina, Serbia: Epidemiological Trends and Implications for Enhanced Surveillance and Vaccination Policy. [PDF]
Ristić M +5 more
europepmc +1 more source
Correction to: Understanding the Sequelae of Invasive Meningococcal Disease in the United States. [PDF]
Marshall GS +5 more
europepmc +1 more source
Genomic analysis of <i>Neisseria meningitidis</i> serogroup W causing invasive meningococcal disease in four travellers from Saudi Arabia, Italy, 2025. [PDF]
Neri A +9 more
europepmc +1 more source

